Coexpression cluster:C129
From FANTOM5_SSTAR
Full id: C129_liver_Hepatocyte_colon_duodenum_temporal_testicular_small
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0005615 | extracellular space | 1.48086432370248e-10 |
GO:0044421 | extracellular region part | 6.57448167385691e-08 |
GO:0046870 | cadmium ion binding | 1.07053834821666e-07 |
GO:0032501 | multicellular organismal process | 1.07098905689507e-07 |
GO:0006629 | lipid metabolic process | 5.39357397914303e-07 |
GO:0005319 | lipid transporter activity | 5.39357397914303e-07 |
GO:0044255 | cellular lipid metabolic process | 5.93014759482007e-07 |
GO:0015918 | sterol transport | 8.58942756579416e-07 |
GO:0030301 | cholesterol transport | 8.58942756579416e-07 |
GO:0006869 | lipid transport | 2.52091414113614e-06 |
GO:0065008 | regulation of biological quality | 3.440761370017e-06 |
GO:0002526 | acute inflammatory response | 5.52163142747491e-06 |
GO:0051239 | regulation of multicellular organismal process | 6.07008552608326e-06 |
GO:0042627 | chylomicron | 8.0558945854026e-06 |
GO:0006810 | transport | 2.80207081469866e-05 |
GO:0005507 | copper ion binding | 2.88256114622693e-05 |
GO:0008202 | steroid metabolic process | 2.88256114622693e-05 |
GO:0051234 | establishment of localization | 4.20686384807624e-05 |
GO:0004866 | endopeptidase inhibitor activity | 5.25691872096465e-05 |
GO:0030414 | protease inhibitor activity | 6.83242618215475e-05 |
GO:0006641 | triacylglycerol metabolic process | 7.69547300248815e-05 |
GO:0009605 | response to external stimulus | 7.69547300248815e-05 |
GO:0030139 | endocytic vesicle | 0.000133068156671684 |
GO:0008203 | cholesterol metabolic process | 0.00013524283622399 |
GO:0006638 | neutral lipid metabolic process | 0.00013524283622399 |
GO:0006639 | acylglycerol metabolic process | 0.00013524283622399 |
GO:0046486 | glycerolipid metabolic process | 0.000148697483236104 |
GO:0006662 | glycerol ether metabolic process | 0.000162087116637339 |
GO:0051179 | localization | 0.000162087116637339 |
GO:0016125 | sterol metabolic process | 0.000238208181255638 |
GO:0050776 | regulation of immune response | 0.000271650017635703 |
GO:0019752 | carboxylic acid metabolic process | 0.000271650017635703 |
GO:0002682 | regulation of immune system process | 0.000271650017635703 |
GO:0006082 | organic acid metabolic process | 0.000271650017635703 |
GO:0006953 | acute-phase response | 0.000278980367605687 |
GO:0004857 | enzyme inhibitor activity | 0.000396218796457818 |
GO:0009611 | response to wounding | 0.000507707147740188 |
GO:0009308 | amine metabolic process | 0.000507707147740188 |
GO:0000267 | cell fraction | 0.000570676404315978 |
GO:0033344 | cholesterol efflux | 0.00058383456311079 |
GO:0006807 | nitrogen compound metabolic process | 0.000707087960943878 |
GO:0032787 | monocarboxylic acid metabolic process | 0.000889754724505307 |
GO:0006954 | inflammatory response | 0.000928048924478177 |
GO:0005737 | cytoplasm | 0.00102394198824895 |
GO:0044444 | cytoplasmic part | 0.0011977275275191 |
GO:0019825 | oxygen binding | 0.00120271997368007 |
GO:0008015 | blood circulation | 0.00120271997368007 |
GO:0003013 | circulatory system process | 0.00120271997368007 |
GO:0005792 | microsome | 0.00123633628213574 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 0.00139492551803167 |
GO:0042598 | vesicular fraction | 0.00139934583542896 |
GO:0030500 | regulation of bone mineralization | 0.00163961905541608 |
GO:0002253 | activation of immune response | 0.00204588633702832 |
GO:0006631 | fatty acid metabolic process | 0.00208076718368457 |
GO:0006952 | defense response | 0.00208076718368457 |
GO:0001501 | skeletal development | 0.00288535090839581 |
GO:0006950 | response to stress | 0.00318817735025831 |
GO:0050778 | positive regulation of immune response | 0.00318817735025831 |
GO:0002684 | positive regulation of immune system process | 0.00324434981061394 |
GO:0030278 | regulation of ossification | 0.00428912329622161 |
GO:0046849 | bone remodeling | 0.00428912329622161 |
GO:0005624 | membrane fraction | 0.00428912329622161 |
GO:0030282 | bone mineralization | 0.00452216305197419 |
GO:0007596 | blood coagulation | 0.00452216305197419 |
GO:0005777 | peroxisome | 0.00452216305197419 |
GO:0042579 | microbody | 0.00452216305197419 |
GO:0050817 | coagulation | 0.00472121610869589 |
GO:0051240 | positive regulation of multicellular organismal process | 0.00491967566122464 |
GO:0048771 | tissue remodeling | 0.00491967566122464 |
GO:0007599 | hemostasis | 0.00491967566122464 |
GO:0006520 | amino acid metabolic process | 0.00543490017068413 |
GO:0046850 | regulation of bone remodeling | 0.00587610010638861 |
GO:0022892 | substrate-specific transporter activity | 0.00620908591586319 |
GO:0051241 | negative regulation of multicellular organismal process | 0.00620908591586319 |
GO:0050381 | unspecific monooxygenase activity | 0.00654385201519291 |
GO:0042552 | myelination | 0.00654385201519291 |
GO:0050878 | regulation of body fluid levels | 0.00740307464757534 |
GO:0006958 | complement activation, classical pathway | 0.00740307464757534 |
GO:0042060 | wound healing | 0.00829211968876683 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 0.00829211968876683 |
GO:0006519 | amino acid and derivative metabolic process | 0.00898918200096567 |
GO:0008366 | axon ensheathment | 0.00898918200096567 |
GO:0008286 | insulin receptor signaling pathway | 0.00898918200096567 |
GO:0007272 | ensheathment of neurons | 0.00898918200096567 |
GO:0016042 | lipid catabolic process | 0.00943506417049335 |
GO:0051704 | multi-organism process | 0.00943506417049335 |
GO:0008610 | lipid biosynthetic process | 0.00943506417049335 |
GO:0008289 | lipid binding | 0.00943506417049335 |
GO:0016247 | channel regulator activity | 0.00943506417049335 |
GO:0048731 | system development | 0.00943506417049335 |
GO:0006956 | complement activation | 0.00943506417049335 |
GO:0002541 | activation of plasma proteins during acute inflammatory response | 0.00943506417049335 |
GO:0048856 | anatomical structure development | 0.00943506417049335 |
GO:0001508 | regulation of action potential | 0.00943506417049335 |
GO:0002018 | renin-angiotensin regulation of aldosterone production | 0.00943506417049335 |
GO:0030568 | plasmin inhibitor activity | 0.00943506417049335 |
GO:0015682 | ferric iron transport | 0.00943506417049335 |
GO:0031643 | positive regulation of myelination | 0.00943506417049335 |
GO:0048143 | astrocyte activation | 0.00943506417049335 |
GO:0031701 | angiotensin receptor binding | 0.00943506417049335 |
GO:0002019 | angiotensin mediated regulation of renal output | 0.00943506417049335 |
GO:0004760 | serine-pyruvate transaminase activity | 0.00943506417049335 |
GO:0031703 | type 2 angiotensin receptor binding | 0.00943506417049335 |
GO:0043395 | heparan sulfate proteoglycan binding | 0.00943506417049335 |
GO:0019375 | galactolipid biosynthetic process | 0.00943506417049335 |
GO:0004397 | histidine ammonia-lyase activity | 0.00943506417049335 |
GO:0046724 | oxalic acid secretion | 0.00943506417049335 |
GO:0060155 | platelet dense granule organization and biogenesis | 0.00943506417049335 |
GO:0043394 | proteoglycan binding | 0.00943506417049335 |
GO:0042866 | pyruvate biosynthetic process | 0.00943506417049335 |
GO:0006682 | galactosylceramide biosynthetic process | 0.00943506417049335 |
GO:0046622 | positive regulation of organ growth | 0.00943506417049335 |
GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate | 0.00943506417049335 |
GO:0051657 | maintenance of organelle localization | 0.00943506417049335 |
GO:0006642 | triacylglycerol mobilization | 0.00943506417049335 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 0.00943506417049335 |
GO:0046904 | calcium oxalate binding | 0.00943506417049335 |
GO:0042756 | drinking behavior | 0.00943506417049335 |
GO:0043691 | reverse cholesterol transport | 0.00943506417049335 |
GO:0015091 | ferric iron transmembrane transporter activity | 0.00943506417049335 |
GO:0001999 | renal response to blood flow during renin-angiotensin regulation of systemic arterial blood pressure | 0.00943506417049335 |
GO:0051659 | maintenance of mitochondrion localization | 0.00943506417049335 |
GO:0047963 | glycine N-choloyltransferase activity | 0.00943506417049335 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 0.00943506417049335 |
GO:0031702 | type 1 angiotensin receptor binding | 0.00943506417049335 |
GO:0006544 | glycine metabolic process | 0.0108073824515304 |
GO:0030198 | extracellular matrix organization and biogenesis | 0.0121622031698151 |
GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 0.0121622031698151 |
GO:0004091 | carboxylesterase activity | 0.0141346188940538 |
GO:0016064 | immunoglobulin mediated immune response | 0.0143731936705695 |
GO:0019724 | B cell mediated immunity | 0.0143731936705695 |
GO:0006487 | protein amino acid N-linked glycosylation | 0.0143731936705695 |
GO:0010324 | membrane invagination | 0.0143731936705695 |
GO:0006897 | endocytosis | 0.0143731936705695 |
GO:0009069 | serine family amino acid metabolic process | 0.0143731936705695 |
GO:0040008 | regulation of growth | 0.0143731936705695 |
GO:0000066 | mitochondrial ornithine transport | 0.0143731936705695 |
GO:0033700 | phospholipid efflux | 0.0143731936705695 |
GO:0014821 | phasic smooth muscle contraction | 0.0143731936705695 |
GO:0003072 | renal regulation of systemic arterial blood pressure by control of peripheral vascular resistence | 0.0143731936705695 |
GO:0004421 | hydroxymethylglutaryl-CoA synthase activity | 0.0143731936705695 |
GO:0033363 | secretory granule organization and biogenesis | 0.0143731936705695 |
GO:0002034 | renin-angiotensin regulation of blood vessel size | 0.0143731936705695 |
GO:0000064 | L-ornithine transmembrane transporter activity | 0.0143731936705695 |
GO:0055091 | phospholipid homeostasis | 0.0143731936705695 |
GO:0002016 | renin-angiotensin regulation of blood volume | 0.0143731936705695 |
GO:0046337 | phosphatidylethanolamine metabolic process | 0.0143731936705695 |
GO:0002035 | brain renin-angiotensin system | 0.0143731936705695 |
GO:0001867 | complement activation, lectin pathway | 0.0143731936705695 |
GO:0008065 | establishment of blood-nerve barrier | 0.0143731936705695 |
GO:0030810 | positive regulation of nucleotide biosynthetic process | 0.0143731936705695 |
GO:0043072 | negative regulation of non-apoptotic programmed cell death | 0.0143731936705695 |
GO:0030816 | positive regulation of cAMP metabolic process | 0.0143731936705695 |
GO:0045981 | positive regulation of nucleotide metabolic process | 0.0143731936705695 |
GO:0030432 | peristalsis | 0.0143731936705695 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 0.0143731936705695 |
GO:0001543 | ovarian follicle rupture | 0.0143731936705695 |
GO:0030349 | syntaxin-13 binding | 0.0143731936705695 |
GO:0042304 | regulation of fatty acid biosynthetic process | 0.0143731936705695 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 0.0143731936705695 |
GO:0019862 | IgA binding | 0.0143731936705695 |
GO:0030819 | positive regulation of cAMP biosynthetic process | 0.0143731936705695 |
GO:0019855 | calcium channel inhibitor activity | 0.0143731936705695 |
GO:0015822 | ornithine transport | 0.0143731936705695 |
GO:0048518 | positive regulation of biological process | 0.015645726955851 |
GO:0031667 | response to nutrient levels | 0.0158459236380062 |
GO:0006066 | alcohol metabolic process | 0.016009523212049 |
GO:0010033 | response to organic substance | 0.0166989084016075 |
GO:0009991 | response to extracellular stimulus | 0.0172364109538812 |
GO:0005625 | soluble fraction | 0.0172364109538812 |
GO:0030246 | carbohydrate binding | 0.0172364109538812 |
GO:0052185 | modification of structure of other organism during symbiotic interaction | 0.0172364109538812 |
GO:0030304 | trypsin inhibitor activity | 0.0172364109538812 |
GO:0051883 | killing of cells in other organism during symbiotic interaction | 0.0172364109538812 |
GO:0046476 | glycosylceramide biosynthetic process | 0.0172364109538812 |
GO:0046329 | negative regulation of JNK cascade | 0.0172364109538812 |
GO:0052331 | hemolysis by organism of red blood cells in other organism during symbiotic interaction | 0.0172364109538812 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 0.0172364109538812 |
GO:0003071 | renal regulation of systemic arterial blood pressure | 0.0172364109538812 |
GO:0046149 | pigment catabolic process | 0.0172364109538812 |
GO:0019836 | hemolysis by symbiont of host red blood cells | 0.0172364109538812 |
GO:0051801 | cytolysis of cells in other organism during symbiotic interaction | 0.0172364109538812 |
GO:0004873 | asialoglycoprotein receptor activity | 0.0172364109538812 |
GO:0001907 | killing by symbiont of host cells | 0.0172364109538812 |
GO:0031640 | killing of cells of another organism | 0.0172364109538812 |
GO:0001897 | cytolysis by symbiont of host cells | 0.0172364109538812 |
GO:0016244 | non-apoptotic programmed cell death | 0.0172364109538812 |
GO:0001885 | endothelial cell development | 0.0172364109538812 |
GO:0046461 | neutral lipid catabolic process | 0.0172364109538812 |
GO:0046487 | glyoxylate metabolic process | 0.0172364109538812 |
GO:0051818 | disruption of cells of other organism during symbiotic interaction | 0.0172364109538812 |
GO:0008453 | alanine-glyoxylate transaminase activity | 0.0172364109538812 |
GO:0044004 | disruption by symbiont of host cells | 0.0172364109538812 |
GO:0051817 | modification of morphology or physiology of other organism during symbiotic interaction | 0.0172364109538812 |
GO:0051715 | cytolysis of cells of another organism | 0.0172364109538812 |
GO:0052332 | modification by organism of cell membrane in other organism during symbiotic interaction | 0.0172364109538812 |
GO:0043070 | regulation of non-apoptotic programmed cell death | 0.0172364109538812 |
GO:0046889 | positive regulation of lipid biosynthetic process | 0.0172364109538812 |
GO:0052111 | modification by symbiont of host structure | 0.0172364109538812 |
GO:0042167 | heme catabolic process | 0.0172364109538812 |
GO:0045335 | phagocytic vesicle | 0.0172364109538812 |
GO:0052025 | modification by symbiont of host cell membrane | 0.0172364109538812 |
GO:0052043 | modification by symbiont of host cellular component | 0.0172364109538812 |
GO:0044003 | modification by symbiont of host morphology or physiology | 0.0172364109538812 |
GO:0052188 | modification of cellular component in other organism during symbiotic interaction | 0.0172364109538812 |
GO:0009891 | positive regulation of biosynthetic process | 0.0172731238559978 |
GO:0048513 | organ development | 0.0177257174712722 |
GO:0032502 | developmental process | 0.017988280443683 |
GO:0002449 | lymphocyte mediated immunity | 0.017988280443683 |
GO:0003008 | system process | 0.018221097311605 |
GO:0006959 | humoral immune response | 0.0192946558716782 |
GO:0008201 | heparin binding | 0.0194307744560461 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0194307744560461 |
GO:0009725 | response to hormone stimulus | 0.0194307744560461 |
GO:0002250 | adaptive immune response | 0.0194307744560461 |
GO:0002443 | leukocyte mediated immunity | 0.0198656814051785 |
GO:0009058 | biosynthetic process | 0.0198656814051785 |
GO:0006907 | pinocytosis | 0.0198656814051785 |
GO:0055062 | phosphate ion homeostasis | 0.0198656814051785 |
GO:0031641 | regulation of myelination | 0.0198656814051785 |
GO:0032366 | intracellular sterol transport | 0.0198656814051785 |
GO:0006545 | glycine biosynthetic process | 0.0198656814051785 |
GO:0001733 | galactosylceramide sulfotransferase activity | 0.0198656814051785 |
GO:0015643 | toxin binding | 0.0198656814051785 |
GO:0046717 | acid secretion | 0.0198656814051785 |
GO:0046620 | regulation of organ growth | 0.0198656814051785 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 0.0198656814051785 |
GO:0001542 | ovulation from ovarian follicle | 0.0198656814051785 |
GO:0030502 | negative regulation of bone mineralization | 0.0198656814051785 |
GO:0014002 | astrocyte development | 0.0198656814051785 |
GO:0032365 | intracellular lipid transport | 0.0198656814051785 |
GO:0050694 | galactose 3-O-sulfotransferase activity | 0.0198656814051785 |
GO:0032367 | intracellular cholesterol transport | 0.0198656814051785 |
GO:0030643 | cellular phosphate ion homeostasis | 0.0198656814051785 |
GO:0016841 | ammonia-lyase activity | 0.0198656814051785 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 0.0198656814051785 |
GO:0046473 | phosphatidic acid metabolic process | 0.0198656814051785 |
GO:0007565 | female pregnancy | 0.0198695617356605 |
GO:0016053 | organic acid biosynthetic process | 0.0206597843310698 |
GO:0046394 | carboxylic acid biosynthetic process | 0.0206597843310698 |
GO:0042157 | lipoprotein metabolic process | 0.0209707789955566 |
GO:0043062 | extracellular structure organization and biogenesis | 0.0209707789955566 |
GO:0065007 | biological regulation | 0.0224329805746186 |
GO:0031214 | biomineral formation | 0.0226204327802265 |
GO:0001503 | ossification | 0.0226204327802265 |
GO:0006694 | steroid biosynthetic process | 0.0226204327802265 |
GO:0016044 | membrane organization and biogenesis | 0.0226204327802265 |
GO:0051646 | mitochondrion localization | 0.0226204327802265 |
GO:0030319 | cellular di-, tri-valent inorganic anion homeostasis | 0.0226204327802265 |
GO:0055061 | di-, tri-valent inorganic anion homeostasis | 0.0226204327802265 |
GO:0046626 | regulation of insulin receptor signaling pathway | 0.0226204327802265 |
GO:0008035 | high-density lipoprotein binding | 0.0226204327802265 |
GO:0030728 | ovulation | 0.0226204327802265 |
GO:0006787 | porphyrin catabolic process | 0.0226204327802265 |
GO:0033015 | tetrapyrrole catabolic process | 0.0226204327802265 |
GO:0030817 | regulation of cAMP biosynthetic process | 0.0226204327802265 |
GO:0019374 | galactolipid metabolic process | 0.0226204327802265 |
GO:0004594 | pantothenate kinase activity | 0.0226204327802265 |
GO:0035265 | organ growth | 0.0226204327802265 |
GO:0006681 | galactosylceramide metabolic process | 0.0226204327802265 |
GO:0020037 | heme binding | 0.0239199444095962 |
GO:0046906 | tetrapyrrole binding | 0.0239199444095962 |
GO:0048878 | chemical homeostasis | 0.0256046491335867 |
GO:0004359 | glutaminase activity | 0.0256046491335867 |
GO:0045923 | positive regulation of fatty acid metabolic process | 0.0256046491335867 |
GO:0001948 | glycoprotein binding | 0.0256046491335867 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 0.0256046491335867 |
GO:0030808 | regulation of nucleotide biosynthetic process | 0.0256046491335867 |
GO:0055081 | anion homeostasis | 0.0256046491335867 |
GO:0005381 | iron ion transmembrane transporter activity | 0.0256046491335867 |
GO:0004465 | lipoprotein lipase activity | 0.0256046491335867 |
GO:0008385 | IkappaB kinase complex | 0.0256046491335867 |
GO:0006349 | genetic imprinting | 0.0256046491335867 |
GO:0030814 | regulation of cAMP metabolic process | 0.0256046491335867 |
GO:0030002 | cellular anion homeostasis | 0.0256046491335867 |
GO:0044429 | mitochondrial part | 0.0256046491335867 |
GO:0042221 | response to chemical stimulus | 0.0258120680052261 |
GO:0009968 | negative regulation of signal transduction | 0.0275711386207889 |
GO:0016192 | vesicle-mediated transport | 0.0282511015481634 |
GO:0046470 | phosphatidylcholine metabolic process | 0.0290563391892623 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 0.0290563391892623 |
GO:0015937 | coenzyme A biosynthetic process | 0.0290563391892623 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 0.0290563391892623 |
GO:0005539 | glycosaminoglycan binding | 0.0299483410283475 |
GO:0002252 | immune effector process | 0.0299483410283475 |
GO:0031967 | organelle envelope | 0.0300571043717113 |
GO:0009056 | catabolic process | 0.0300571043717113 |
GO:0031975 | envelope | 0.0302399763811864 |
GO:0045087 | innate immune response | 0.0303929885195778 |
GO:0009409 | response to cold | 0.0303929885195778 |
GO:0019627 | urea metabolic process | 0.0303929885195778 |
GO:0009267 | cellular response to starvation | 0.0303929885195778 |
GO:0048708 | astrocyte differentiation | 0.0303929885195778 |
GO:0006677 | glycosylceramide metabolic process | 0.0303929885195778 |
GO:0051145 | smooth muscle cell differentiation | 0.0303929885195778 |
GO:0000050 | urea cycle | 0.0303929885195778 |
GO:0046513 | ceramide biosynthetic process | 0.0303929885195778 |
GO:0019217 | regulation of fatty acid metabolic process | 0.0303929885195778 |
GO:0050886 | endocrine process | 0.0303929885195778 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 0.0303929885195778 |
GO:0018445 | prothoracicotrophic hormone activity | 0.0303929885195778 |
GO:0030279 | negative regulation of ossification | 0.0303929885195778 |
GO:0001976 | regulation of systemic arterial blood pressure by neurological process | 0.0303929885195778 |
GO:0006658 | phosphatidylserine metabolic process | 0.0303929885195778 |
GO:0046890 | regulation of lipid biosynthetic process | 0.0303929885195778 |
GO:0043410 | positive regulation of MAPKKK cascade | 0.0303929885195778 |
GO:0043603 | amide metabolic process | 0.0303929885195778 |
GO:0031646 | positive regulation of neurological process | 0.0303929885195778 |
GO:0016290 | palmitoyl-CoA hydrolase activity | 0.0303929885195778 |
GO:0030247 | polysaccharide binding | 0.0304763743155302 |
GO:0016043 | cellular component organization and biogenesis | 0.0307704570726559 |
GO:0030170 | pyridoxal phosphate binding | 0.0307704570726559 |
GO:0005739 | mitochondrion | 0.0307704570726559 |
GO:0007275 | multicellular organismal development | 0.031239155641175 |
GO:0016023 | cytoplasmic membrane-bound vesicle | 0.0320626442860655 |
GO:0031988 | membrane-bound vesicle | 0.0324873069080913 |
GO:0042730 | fibrinolysis | 0.0324873069080913 |
GO:0003014 | renal system process | 0.0324873069080913 |
GO:0046520 | sphingoid biosynthetic process | 0.0324873069080913 |
GO:0050766 | positive regulation of phagocytosis | 0.0324873069080913 |
GO:0016880 | acid-ammonia (or amide) ligase activity | 0.0324873069080913 |
GO:0003963 | RNA-3'-phosphate cyclase activity | 0.0324873069080913 |
GO:0016211 | ammonia ligase activity | 0.0324873069080913 |
GO:0050777 | negative regulation of immune response | 0.0324873069080913 |
GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 0.0324873069080913 |
GO:0012505 | endomembrane system | 0.0329919746541193 |
GO:0005102 | receptor binding | 0.0340520350007429 |
GO:0001871 | pattern binding | 0.0342283290911175 |
GO:0002683 | negative regulation of immune system process | 0.0343805568152402 |
GO:0031669 | cellular response to nutrient levels | 0.0343805568152402 |
GO:0050764 | regulation of phagocytosis | 0.0343805568152402 |
GO:0006140 | regulation of nucleotide metabolic process | 0.0343805568152402 |
GO:0045777 | positive regulation of blood pressure | 0.0343805568152402 |
GO:0045834 | positive regulation of lipid metabolic process | 0.0343805568152402 |
GO:0001658 | ureteric bud branching | 0.0343805568152402 |
GO:0008200 | ion channel inhibitor activity | 0.0343805568152402 |
GO:0004467 | long-chain-fatty-acid-CoA ligase activity | 0.0343805568152402 |
GO:0050702 | interleukin-1 beta secretion | 0.0343805568152402 |
GO:0015645 | fatty-acid ligase activity | 0.0343805568152402 |
GO:0030212 | hyaluronan metabolic process | 0.0343805568152402 |
GO:0016248 | channel inhibitor activity | 0.0343805568152402 |
GO:0007243 | protein kinase cascade | 0.0365088409130551 |
GO:0005159 | insulin-like growth factor receptor binding | 0.0365088409130551 |
GO:0043524 | negative regulation of neuron apoptosis | 0.0365088409130551 |
GO:0005246 | calcium channel regulator activity | 0.0365088409130551 |
GO:0009070 | serine family amino acid biosynthetic process | 0.0365088409130551 |
GO:0051591 | response to cAMP | 0.0365088409130551 |
GO:0046851 | negative regulation of bone remodeling | 0.0365088409130551 |
GO:0017127 | cholesterol transporter activity | 0.0365088409130551 |
GO:0014070 | response to organic cyclic substance | 0.0365088409130551 |
GO:0015936 | coenzyme A metabolic process | 0.0365088409130551 |
GO:0045446 | endothelial cell differentiation | 0.0365088409130551 |
GO:0050701 | interleukin-1 secretion | 0.0365088409130551 |
GO:0046903 | secretion | 0.0373811331880424 |
GO:0031090 | organelle membrane | 0.0384406423736267 |
GO:0016298 | lipase activity | 0.0384406423736267 |
GO:0051384 | response to glucocorticoid stimulus | 0.0388119603610069 |
GO:0040018 | positive regulation of multicellular organism growth | 0.0388119603610069 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 0.0388119603610069 |
GO:0030195 | negative regulation of blood coagulation | 0.0388119603610069 |
GO:0005537 | mannose binding | 0.0388119603610069 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 0.0388119603610069 |
GO:0006548 | histidine catabolic process | 0.0412214045994903 |
GO:0021782 | glial cell development | 0.0412214045994903 |
GO:0031960 | response to corticosteroid stimulus | 0.0412214045994903 |
GO:0015248 | sterol transporter activity | 0.0412214045994903 |
GO:0009077 | histidine family amino acid catabolic process | 0.0412214045994903 |
GO:0042594 | response to starvation | 0.0412214045994903 |
GO:0030193 | regulation of blood coagulation | 0.0412214045994903 |
GO:0000165 | MAPKKK cascade | 0.0415561401497214 |
GO:0031966 | mitochondrial membrane | 0.0418541795420645 |
GO:0016886 | ligase activity, forming phosphoric ester bonds | 0.0436531434065266 |
GO:0048659 | smooth muscle cell proliferation | 0.0436531434065266 |
GO:0050821 | protein stabilization | 0.0436531434065266 |
GO:0031668 | cellular response to extracellular stimulus | 0.0436531434065266 |
GO:0042803 | protein homodimerization activity | 0.0450782411214411 |
GO:0031410 | cytoplasmic vesicle | 0.0457640289410509 |
GO:0008206 | bile acid metabolic process | 0.0457640289410509 |
GO:0006625 | protein targeting to peroxisome | 0.0457640289410509 |
GO:0009247 | glycolipid biosynthetic process | 0.0457640289410509 |
GO:0043408 | regulation of MAPKKK cascade | 0.0457640289410509 |
GO:0016840 | carbon-nitrogen lyase activity | 0.0457640289410509 |
GO:0050819 | negative regulation of coagulation | 0.0457640289410509 |
GO:0001558 | regulation of cell growth | 0.0462517194614314 |
GO:0005740 | mitochondrial envelope | 0.0465941973071202 |
GO:0031982 | vesicle | 0.0465941973071202 |
GO:0001568 | blood vessel development | 0.0468358300759216 |
GO:0048519 | negative regulation of biological process | 0.0470624262182418 |
GO:0001944 | vasculature development | 0.0470624262182418 |
GO:0050818 | regulation of coagulation | 0.0470624262182418 |
GO:0019865 | immunoglobulin binding | 0.0470624262182418 |
GO:0003073 | regulation of systemic arterial blood pressure | 0.0470624262182418 |
GO:0042310 | vasoconstriction | 0.0470624262182418 |
GO:0043574 | peroxisomal transport | 0.0470624262182418 |
GO:0016050 | vesicle organization and biogenesis | 0.0470624262182418 |
GO:0033554 | cellular response to stress | 0.0470624262182418 |
GO:0004806 | triacylglycerol lipase activity | 0.0491049780645851 |
GO:0001906 | cell killing | 0.0491049780645851 |
GO:0050852 | T cell receptor signaling pathway | 0.0491049780645851 |
GO:0055088 | lipid homeostasis | 0.0491049780645851 |
GO:0048029 | monosaccharide binding | 0.0491049780645851 |
GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer | 0.0491049780645851 |
GO:0015485 | cholesterol binding | 0.0491049780645851 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.